AXS Investments LLC recently announced the acquisition of new stake in cbdMD Inc (AMEX:YCBD). The institutional investor has increased its shareholding in the Healthcare company by 72.33% to 64187.0 shares with purchase of 26940.0 shares. This fresh investment now brings its stake to 2.25% valued currently at $44931.0. In addition, Renaissance Technologies LLC raised its holdings by 5700.0 to 26911.0 shares.
With over 41.17 million cbdMD Inc (YCBD) shares trading Friday and a closing price of $1.04 on the day, the dollar volume was approximately $42.81 million. The shares have shown a negative half year performance of -25.71% and its price on 12/29/23 gained nearly 31.66%. Currently, there are 2.96M common shares owned by the public and among those 2.42M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Insiders at the company have transacted a total of 5 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 4 of these insider trades were purchases, accounting for 20,000 shares. Insider sales of the common stock occurred on 1 occasions, with total insider shares sold totaling 5,000 shares.
The top 3 mutual fund holders in cbdMD Inc are AXS Cannabis ETF, Vanguard Extended Market Index Fu, and Amplify Seymour Cannabis ETF. AXS Cannabis ETF owns 0.11 million shares of the company’s stock, all valued at over $74294.0. Amplify Seymour Cannabis ETF now owns shares totaling to 0.43% of the shares outstanding.
Shares of cbdMD Inc (AMEX: YCBD) opened at $1.28, up $0.49 from a prior closing price of $0.79. However, the script later moved the day high at 1.7300, up 31.66%. The company’s stock has a 5-day price change of 55.87% and 0.48% over the past three months. YCBD shares are trading -89.82% year to date (YTD), with the 12-month market performance down to -89.49% lower. It has a 12-month low price of $0.56 and touched a high of $17.06 over the same period. YCBD has an average intraday trading volume of 27.89K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 46.33%, 41.41%, and -52.88% respectively.
Institutional ownership of cbdMD Inc (AMEX: YCBD) shares accounts for 5.72% of the company’s 2.96M shares outstanding. Mutual fund holders own 0.73%, while other institutional holders and individual stakeholders account for 5.20% and — respectively.
It has a market capitalization of $3.08M and a beta (3y monthly) value of 2.25. The earnings-per-share (ttm) stands at -$12.30. Price movements for the stock have been influenced by the stock’s volatility, which stands at 25.51% over the week and 13.66% over the month.
Analysts forecast that cbdMD Inc (YCBD) will achieve an EPS of -$0.74 for the current quarter, -$0.7 for the next quarter and -$0.95 for 2025. The lowest estimate earnings-per-share for the quarter is -$0.74 while analysts give the company a high EPS estimate of -$0.74. Earnings per share for the fiscal year are expected to increase by 82.88%, and 58.33% over the next financial year.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 1 brokerage firm advisors rate cbdMD Inc (YCBD) as a “Strong Buy” at a consensus score of 1.00. Specifically, 1 Wall Street analysts polled rate the stock as a buy, while 0 of the 1 advise that investors “hold,” and 0 rated it as a “Sell.”
